HKEX: 6699 - Angelalign Technology Inc.

Yield per half year: -4.07%
Dividend yield: +3.13%
Sector: Healthcare

Angelalign Technology Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
152.75 35.42 331.31% 149.64 +2.08%
P/S 5.53 7.59 -27.06%
P/BV 2.4 3.68 -34.95%
P/FCF 226.77 55.3 310.1%
Ev/Ebitda 24.18 2.91 731.53%
Ev/S 5.22 23.72 -77.97%
Ev/FCF 150.34 63.78 135.71%
E/P 0.0046 0.0326 -85.9%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
25.1 -11.9 -310.9% 23.24 +8.02%
ROE 1.54 5.19 -70.32%
ROA 1.16 3.47 -66.65%
ROIC 0 0 0%
ROS 3.62 -11.49 -131.51%
ROCE 0 6.04 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.0885 0.7755 -88.59% 0.0885 -0%
Nеt Debt/Ebitda 0 0.0127 -100%
Debt/Ratio 0.0059 0.1229 -95.17%
Debt/Equity 0.0657 0.802 -91.81%
Debt/Net Income 0.5273 1.76 -69.99%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
7.83/10
3.13 5.7 -45.09% 1.66 +88.98%
Number of years of dividend growth 0 1.13 -100%
DSI 0.875 0.5838 49.88%
Average dividend growth -0.762 3.2 -123.79%
Average percentage for 5 years 1.66 4.95 -66.56%
Average percentage for payments 118.25 23.96 393.51%
Difference from average difference in sector -2.57

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
128.51 28.69 347.93%
Growth impulse Ebitda in 5 years 230.61 -40.52 -669.13%
Growth impulse Net Income in 5 years -22.32 94.84 -123.53%
Growth impulse FCF in 5 years -83.05 91.41 -190.85%
Growth impulse EPS in 5 years 540.16 -118.14 -557.22%
IP Score
5.26/10

Similar companies

JD Health International Inc.

WuXi Biologics (Cayman) Inc.

WuXi AppTec Co., Ltd.

CSPC Pharmaceutical Group Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription